{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:25:39Z","timestamp":1751538339158},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologe"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00117-021-00946-9","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T17:04:57Z","timestamp":1641229497000},"page":"247-252","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lokale und lokoregion\u00e4re Therapie des intrahepatischen Cholangiokarzinoms"],"prefix":"10.1007","volume":"62","author":[{"given":"Frank","family":"Wacker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Dewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"issue":"11","key":"946_CR1","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1055\/s-0033-1355841","volume":"51","author":"T Greten","year":"2013","unstructured":"Greten\u00a0T, Malek\u00a0N, Schmidt\u00a0S et\u00a0al (2013) Diagnostik und Therapie des hepatozellul\u00e4ren Karzinoms. Z\u00a0Gastroenterol 51(11):1269\u20131326. https:\/\/doi.org\/10.1055\/s-0033-1355841","journal-title":"Z Gastroenterol"},{"key":"946_CR2","doi-asserted-by":"crossref","unstructured":"Leitlinienprogramm Onkologie (2021) S3-Leitlinie Diagnostik und Therapie des Hepatozellul\u00e4ren Karzinoms und bili\u00e4rer Karzinome. Diagnostik und Therapie des Hepatozellul\u00e4ren Karzinoms und bili\u00e4rer Karzinome. https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/hcc-und-biliaere-karzinome\/. Zugegriffen: 8. Juli 2021","DOI":"10.1055\/a-1510-4568"},{"issue":"2","key":"946_CR3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/liv.13954","volume":"39","author":"D Walter","year":"2019","unstructured":"Walter\u00a0D, Ferstl\u00a0P, Waidmann\u00a0O et\u00a0al (2019) Cholangiocarcinoma in Germany: epidemiologic trends and impact of misclassification. Liver Int 39(2):316\u2013323. https:\/\/doi.org\/10.1111\/liv.13954","journal-title":"Liver Int"},{"issue":"9","key":"946_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales\u00a0JM, Marin\u00a0JJG, Lamarca\u00a0A et\u00a0al (2020) Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 17(9):557\u2013588. https:\/\/doi.org\/10.1038\/s41575-020-0310-z","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"946_CR5","doi-asserted-by":"publisher","first-page":"v28","DOI":"10.1093\/annonc\/mdw324","volume":"27","author":"JW Valle","year":"2016","unstructured":"Valle\u00a0JW, Borbath\u00a0I, Khan\u00a0SA, Huguet\u00a0F, Gruenberger\u00a0T, Arnold\u00a0D (2016) Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 27:v28\u2013v37. https:\/\/doi.org\/10.1093\/annonc\/mdw324","journal-title":"Ann Oncol"},{"issue":"6","key":"946_CR6","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater\u00a0J, Galle\u00a0PR, Khan\u00a0SA et\u00a0al (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J\u00a0Hepatol 60(6):1268\u20131289. https:\/\/doi.org\/10.1016\/j.jhep.2014.01.021","journal-title":"J Hepatol"},{"issue":"5","key":"946_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales\u00a0JM, Cardinale\u00a0V, Carpino\u00a0G et al (2016) Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European network for the study of cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol 13(5):261\u2013280. https:\/\/doi.org\/10.1038\/nrgastro.2016.51","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"946_CR8","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.dld.2020.08.030","volume":"52","author":"D Alvaro","year":"2020","unstructured":"Alvaro\u00a0D, Hassan\u00a0C, Cardinale\u00a0V et\u00a0al (2020) Italian clinical practice guidelines on cholangiocarcinoma\u2014part II: treatment. Dig Liver Dis 52(12):1430\u20131442. https:\/\/doi.org\/10.1016\/j.dld.2020.08.030","journal-title":"Dig Liver Dis"},{"key":"946_CR9","unstructured":"NCCN guidline (2021) Homepage. https:\/\/www.nccn.org\/. Zugegriffen: 8. Juli 2021"},{"issue":"3","key":"946_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1542-3565(04)00005-9","volume":"2","author":"MA Eloubeidi","year":"2004","unstructured":"Eloubeidi\u00a0MA, Chen\u00a0VK, Jhala\u00a0NC et al (2004) Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin Gastroenterol Hepatol 2(3):209\u2013213. https:\/\/doi.org\/10.1016\/S1542-3565(04)00005-9","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"S1","key":"946_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/liv.14086","volume":"39","author":"A Forner","year":"2019","unstructured":"Forner\u00a0A, Vidili\u00a0G, Rengo\u00a0M, Bujanda\u00a0L, Ponz-Sarvis\u00e9\u00a0M, Lamarca\u00a0A (2019) Clinical presentation, diagnosis and staging of cholangiocarcinoma. Liver Int 39(S1):98\u2013107. https:\/\/doi.org\/10.1111\/liv.14086","journal-title":"Liver Int"},{"issue":"8","key":"946_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/hpb.12441","volume":"17","author":"SM Weber","year":"2015","unstructured":"Weber\u00a0SM, Ribero\u00a0D, O\u2019Reilly\u00a0EM, Kokudo\u00a0N, Miyazaki\u00a0M, Pawlik\u00a0TM (2015) Intrahepatic cholangiocarcinoma: expert consensus statement. HPB 17(8):669\u2013680. https:\/\/doi.org\/10.1111\/hpb.12441","journal-title":"HPB"},{"issue":"3","key":"946_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/RMR.0000000000000146","volume":"27","author":"J Weiss","year":"2018","unstructured":"Weiss\u00a0J, Hoffmann\u00a0R, Clasen\u00a0S (2018) MR-guided liver interventions. Top Magn Reson Imaging 27(3):163\u2013170. https:\/\/doi.org\/10.1097\/RMR.0000000000000146","journal-title":"Top Magn Reson Imaging"},{"issue":"8","key":"946_CR14","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1007\/s00330-015-4097-1","volume":"26","author":"M Moche","year":"2016","unstructured":"Moche\u00a0M, Heinig\u00a0S, Garnov\u00a0N et al (2016) Navigated MRI-guided liver biopsies in a\u00a0closed-bore scanner: experience in 52\u00a0patients. Eur Radiol 26(8):2462\u20132470. https:\/\/doi.org\/10.1007\/s00330-015-4097-1","journal-title":"Eur Radiol"},{"issue":"2","key":"946_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s00108-019-00725-8","volume":"61","author":"JB Hinrichs","year":"2020","unstructured":"Hinrichs\u00a0JB, Wacker\u00a0FK (2020) Lokoregion\u00e4re und lokal ablative Therapien von Lebertumoren. Internist 61(2):158\u2013163. https:\/\/doi.org\/10.1007\/s00108-019-00725-8","journal-title":"Internist"},{"issue":"1","key":"946_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/02656736.2019.1571247","volume":"36","author":"C Xu","year":"2019","unstructured":"Xu\u00a0C, Li\u00a0L, Xu\u00a0W et al (2019) Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma: intermediate-term results. Int J Hyperthermia 36(1):350\u2013357. https:\/\/doi.org\/10.1080\/02656736.2019.1571247","journal-title":"Int J Hyperthermia"},{"issue":"11","key":"946_CR17","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1245\/s10434-013-3035-1","volume":"20","author":"S-J Zhang","year":"2013","unstructured":"Zhang\u00a0S\u2011J, Hu\u00a0P, Wang\u00a0N et al (2013) Thermal ablation versus repeated hepatic resection for recurrent Intrahepatic cholangiocarcinoma. Ann Surg Oncol 20(11):3596\u20133602. https:\/\/doi.org\/10.1245\/s10434-013-3035-1","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"946_CR18","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s00464-016-5105-5","volume":"31","author":"P Yazici","year":"2017","unstructured":"Yazici\u00a0P, Akyuz\u00a0M, Yigitbas\u00a0H et\u00a0al (2017) A comparison of perioperative outcomes in elderly patients with malignant liver tumors undergoing laparoscopic liver resection versus radiofrequency ablation. Surg Endosc 31(3):1269\u20131274. https:\/\/doi.org\/10.1007\/s00464-016-5105-5","journal-title":"Surg Endosc"},{"issue":"7","key":"946_CR19","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/liv.13382","volume":"37","author":"A Cucchetti","year":"2017","unstructured":"Cucchetti\u00a0A, Cappelli\u00a0A, Mosconi\u00a0C et al (2017) Improving patient selection for selective internal radiation therapy of intra-hepatic cholangiocarcinoma: a meta-regression study. Liver Int 37(7):1056\u20131064. https:\/\/doi.org\/10.1111\/liv.13382","journal-title":"Liver Int"},{"issue":"8","key":"946_CR20","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jvir.2018.04.001","volume":"29","author":"A Gangi","year":"2018","unstructured":"Gangi\u00a0A, Shah\u00a0J, Hatfield\u00a0N et al (2018) Intrahepatic cholangiocarcinoma treated with transarterial yttrium-90 glass microsphere radioembolization: results of a\u00a0single institution retrospective study. J\u00a0Vasc Interv Radiol 29(8):1101\u20131108. https:\/\/doi.org\/10.1016\/j.jvir.2018.04.001","journal-title":"J Vasc Interv Radiol"},{"issue":"10","key":"946_CR21","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s00259-018-3990-7","volume":"45","author":"V Manceau","year":"2018","unstructured":"Manceau\u00a0V, Palard\u00a0X, Rolland\u00a0Y et al (2018) A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a\u00a0combination of chemotherapy and 90Y-loaded glass microsphere selective internal radiation therapy. Eur J Nucl Med Mol Imaging 45(10):1731\u20131741. https:\/\/doi.org\/10.1007\/s00259-018-3990-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"946_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/jso.23781","volume":"111","author":"LM Boehm","year":"2015","unstructured":"Boehm\u00a0LM, Jayakrishnan\u00a0TT, Miura\u00a0JT et\u00a0al (2015) Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma. J\u00a0Surg Oncol 111(2):213\u2013220. https:\/\/doi.org\/10.1002\/jso.23781","journal-title":"J Surg Oncol"},{"issue":"6","key":"946_CR23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10585-020-10057-9","volume":"37","author":"CLA Dewald","year":"2020","unstructured":"Dewald\u00a0CLA, Becker\u00a0LS, Maschke\u00a0SK et al (2020) Percutaneous isolated hepatic perfusion (chemosaturation) with melphalan following right hemihepatectomy in patients with cholangiocarcinoma and metastatic uveal melanoma: peri- and post-interventional adverse events and therapy response compared to a\u00a0matched group without prior liver surgery. Clin Exp Metastasis 37(6):683\u2013692. https:\/\/doi.org\/10.1007\/s10585-020-10057-9","journal-title":"Clin Exp Metastasis"},{"issue":"4","key":"946_CR24","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1007\/s00330-018-5729-z","volume":"29","author":"S Marquardt","year":"2019","unstructured":"Marquardt\u00a0S, Kirstein\u00a0MM, Br\u00fcning\u00a0R et al (2019) Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival. Eur Radiol 29(4):1882\u20131892. https:\/\/doi.org\/10.1007\/s00330-018-5729-z","journal-title":"Eur Radiol"},{"issue":"11","key":"946_CR25","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1007\/s00432-020-03289-5","volume":"146","author":"L Sch\u00f6nfeld","year":"2020","unstructured":"Sch\u00f6nfeld\u00a0L, Hinrichs\u00a0JB, Marquardt\u00a0S et\u00a0al (2020) Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma. J\u00a0Cancer Res Clin Oncol 146(11):3003\u20133012. https:\/\/doi.org\/10.1007\/s00432-020-03289-5","journal-title":"J Cancer Res Clin Oncol"},{"key":"946_CR26","doi-asserted-by":"publisher","first-page":"8732521","DOI":"10.1155\/2016\/8732521","volume":"2016","author":"R Seidensticker","year":"2016","unstructured":"Seidensticker\u00a0R, Seidensticker\u00a0M, Doegen\u00a0K et\u00a0al (2016) Extensive use of interventional therapies improves survival in unresectable or recurrent Intrahepatic cholangiocarcinoma. Gastroenterol Res Pract 2016:8732521. https:\/\/doi.org\/10.1155\/2016\/8732521","journal-title":"Gastroenterol Res Pract"},{"issue":"12","key":"946_CR27","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1245\/s10434-013-3127-y","volume":"20","author":"O Hyder","year":"2013","unstructured":"Hyder\u00a0O, Marsh\u00a0JW, Salem\u00a0R et al (2013) Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a\u00a0multi-institutional analysis. Ann Surg Oncol 20(12):3779\u20133786. https:\/\/doi.org\/10.1245\/s10434-013-3127-y","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"946_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jamaoncol.2019.3702","volume":"6","author":"J Edeline","year":"2020","unstructured":"Edeline\u00a0J, Touchefeu\u00a0Y, Guiu\u00a0B et al (2020) Radioembolization plus chemotherapy for first-line treatment of locally advanced Intrahepatic cholangiocarcinoma: a phase 2 clinical trial. JAMA Oncol 6(1):51. https:\/\/doi.org\/10.1001\/jamaoncol.2019.3702","journal-title":"JAMA Oncol"},{"issue":"1","key":"946_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1001\/jamaoncol.2019.3718","volume":"6","author":"A Cercek","year":"2020","unstructured":"Cercek\u00a0A, Boerner\u00a0T, Tan\u00a0BR et\u00a0al (2020) Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma: a phase 2 clinical trial. JAMA Oncol 6(1):60. https:\/\/doi.org\/10.1001\/jamaoncol.2019.3718","journal-title":"JAMA Oncol"},{"issue":"9","key":"946_CR30","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00270-020-02569-4","volume":"43","author":"I Bargellini","year":"2020","unstructured":"Bargellini\u00a0I, Mosconi\u00a0C, Pizzi\u00a0G et al (2020) Yttrium-90 radioembolization in unresectable Intrahepatic cholangiocarcinoma: results of a\u00a0multicenter retrospective study. Cardiovasc Intervent Radiol 43(9):1305\u20131314. https:\/\/doi.org\/10.1007\/s00270-020-02569-4","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"946_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00259-018-4199-5","volume":"46","author":"H Bourien","year":"2019","unstructured":"Bourien\u00a0H, Palard\u00a0X, Rolland\u00a0Y et al (2019) Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a\u00a0large single-center experience. Eur J Nucl Med Mol Imaging 46(3):669\u2013676. https:\/\/doi.org\/10.1007\/s00259-018-4199-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"946_CR32","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.jvir.2020.02.008","volume":"31","author":"S Buettner","year":"2020","unstructured":"Buettner\u00a0S, Braat\u00a0AJAT, Margonis\u00a0GA et al (2020) Yttrium-90 radioembolization in Intrahepatic cholangiocarcinoma: a multicenter retrospective analysis. J\u00a0Vasc Interv Radiol 31(7):1035\u20131043.e2. https:\/\/doi.org\/10.1016\/j.jvir.2020.02.008","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"946_CR33","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jvir.2019.09.028","volume":"31","author":"CD Malone","year":"2020","unstructured":"Malone\u00a0CD, Gibby\u00a0W, Tsai\u00a0R et al (2020) Outcomes of yttrium-90 radioembolization for unresectable combined biphenotypic hepatocellular-cholangiocarcinoma. J\u00a0Vasc Interv Radiol 31(5):701\u2013709. https:\/\/doi.org\/10.1016\/j.jvir.2019.09.028","journal-title":"J Vasc Interv Radiol"},{"issue":"10","key":"946_CR34","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1245\/s10434-020-08486-7","volume":"27","author":"D Riby","year":"2020","unstructured":"Riby\u00a0D, Mazzotta\u00a0AD, Bergeat\u00a0D et\u00a0al (2020) Downstaging with radioembolization or chemotherapy for initially unresectable intrahepatic cholangiocarcinoma. Ann Surg Oncol 27(10):3729\u20133737. https:\/\/doi.org\/10.1245\/s10434-020-08486-7","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"946_CR35","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1002\/hep.31598","volume":"73","author":"A Lamarca","year":"2021","unstructured":"Lamarca\u00a0A, Santos-Laso\u00a0A, Utpatel\u00a0K et al (2021) Liver metastases of intrahepatic cholangiocarcinoma: implications for an updated staging system. Hepatology 73(6):2311\u20132325. https:\/\/doi.org\/10.1002\/hep.31598","journal-title":"Hepatology"},{"issue":"1","key":"946_CR36","doi-asserted-by":"publisher","first-page":"e1002207","DOI":"10.1371\/journal.pmed.1002207","volume":"14","author":"RWM Vernooij","year":"2017","unstructured":"Vernooij\u00a0RWM, Alonso-Coello\u00a0P, Brouwers\u00a0M, Garc\u00eda\u00a0LM, Panel\u00a0C (2017) Reporting items for updated clinical guidelines: checklist for the reporting of updated guidelines (checkup). PLoS Med 14(1):e1002207. https:\/\/doi.org\/10.1371\/journal.pmed.1002207","journal-title":"PLoS Med"},{"issue":"1","key":"946_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00120-011-2714-4","volume":"51","author":"L Wei\u00dfbach","year":"2012","unstructured":"Wei\u00dfbach\u00a0L (2012) Welche Inhalte sollte eine \u201eliving guideline\u201c besetzen? Urologe 51(1):57\u201359. https:\/\/doi.org\/10.1007\/s00120-011-2714-4","journal-title":"Urologe"}],"container-title":["Der Radiologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-021-00946-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00117-021-00946-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-021-00946-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T15:02:48Z","timestamp":1646319768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00117-021-00946-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["946"],"URL":"https:\/\/doi.org\/10.1007\/s00117-021-00946-9","relation":{},"ISSN":["0033-832X","1432-2102"],"issn-type":[{"value":"0033-832X","type":"print"},{"value":"1432-2102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,3]]},"assertion":[{"value":"29 November 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0Wacker weist auf folgende Beziehungen hin: Mitarbeit in einem Wissenschaftlichen Beirat und Schulungst\u00e4tigkeit: BTG, SIRTEX, Delcath Systems Forschungsvorhaben\/Durchf\u00fchrung klinischer Studien (institutional grant): Delcath Systems. C.\u00a0Dewald weist auf folgende Beziehungen hin: DFG Clinician Scientist F\u00f6rderung der MHH \u201ePRACTIS\u201c.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}